TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Melissa Angell

Melissa Angell

Articles From This Author

Why You Can Thank Millennials for the Booming $70 Billion Pet Industry
HEALTH

Why You Can Thank Millennials for the Booming $70 Billion Pet Industry

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
HEALTH

Cramer: Every time I see Pfizer quarter, I recognize why they needed to do the Allergen deal

Spicer Comments Rattle Marijuana Industry
HEALTH

Now That's a Switch: Longtime Tomato Grower to Fill Greenhouse With Weed

Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
HEALTH

$AGN posted $4 billion in revenue in the aesthetics division

Will Chipotle Be Able to Wall Off Its Problems When It Reports Earnings?
OPINION

Here's How You Can Score a Free Burrito

Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe
HEALTH

Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe

Twitter Stock Jumps After Mark Cuban Buys Shares
INVESTING

Billionaire Mark Cuban: The Rise of Technology Will Cause a Lot of Unemployment

Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff
HEALTH

The Pharma Giant Reports its Earnings Tomorrow Morning.

Teamsters Wary of McKesson's Promise to Split Top Roles
HEALTH

Teamsters Wary of McKesson's Promise to Split Top Roles

Now, You Can Buy Shares of Popular Pro-Pot Periodical High Times
HEALTH

Now, You Can Buy Shares of Popular Pro-Pot Periodical High Times

Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson
MERGERS AND ACQUISITIONS

The "vote no" campaign led by the International Brotherhood of Teamsters against $MCK succeeds

Universal Health Services Upgraded at Mizuho, Stock Rises as Obamacare Remains
MERGERS AND ACQUISITIONS

Hospital Operators Sink Amid Healthcare Confusion

Eyes Are on McKesson's Guidance
HEALTH

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day
HEALTH

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

European Pharma Companies Slip on MS Pricing Probe
HEALTH

Kala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep Coming

Vertex Pharmaceuticals Stock Surging on Positive Trial Data
HEALTH

Some Analysts Predict Revenue to Triple

P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds
BANKRUPTCY

Valeant is working to repay some $30 billion in debt.

Konica Minolta and Ambry Pair to Accelerate in a New Field—Precision Medicine
STOCKS

Konica and Ambry Pairing to Accelerate Precision Medicine

Konica Minolta and Ambry Pair to Accelerate in a New Field—Precision Medicine
MERGERS AND ACQUISITIONS

Konica and Ambry Pairing to Accelerate Precision Medicine

Healthcare Stocks Sliding on Talks of Revived 'Trumpcare' Bill
STOCKS

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

Bunge Stock Rises After It Hires JPMorgan and Shearman & Sterling to Defend Against Takeover Bid
HEALTH

Move Over GMO's: IPO for Gene Editor Calyxt Launches Next Week

Bristol-Myers 'Is Back' and Could Soar Another 14%
STOCKS

Bristol Myers vies to be king of immune-boosting cancer drugs with new trial update

Alexion Shares Drop Amid Executive Changes
HEALTH

Alexion Can't Stay Out of the Spotlight

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
HEALTH

Celgene Enters PD1 Market with BeiGene Deal

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
HEALTH

Pfizer has left the building

Here's the Latest on Four New Biotech IPOs
STOCKS

Here's the Latest on Four New Biotech IPOs

Martin Shkreli Kicked Off Twitter for Harassing Female Journalists Like Me
HEALTH

"There is no longer any cash at the fund level" Shkreli wrote to his investors.

Juror Selection In Martin Shkreli Case Drags Into a Third Day
STOCKS

Could an exhaustive juror search be part of the Pharma Bro's master plan?

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case
CORPORATE GOVERNANCE

Shkreli's Lawyer Attempts to Ban Press...Again

Martin Shkreli Kicked Off Twitter for Harassing Female Journalists Like Me
HEALTH

The jury selection process for Shkreli's trial got underway Monday and is expected to continue Tues.

Pharma Bro's Trial to Begin Monday
HEALTH

Pharma Bro's Trial to Begin Today

Merck Keytruda-Chemo ASCO '17 Update Shows Lung Cancer Survival Trend
HEALTH

Could Merck and Leap Union Be the One for Keytruda?

Healthcare Stocks Mixed Following President Trump's Comments on Senate Bill
HEALTH

Breaking Down the Senate Healthcare Bill

Walgreens Stock Lower in Premarket After Earnings, Revenue Miss
HEALTH

Hey Big Pharma, Meet the Better Care Reconciliation Act

FDA Commissioner Takes on Big Pharma
STOCKS

FDA Commissioner Takes on Big Pharma

French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal
HEALTH

Regeneron Soars After Eye Drug Competitor Novartis Releases Positive Data

Amazon, Whole Foods: The Deal That Almost Wasn't?
MERGERS AND ACQUISITIONS

Local NYC Grocers Unhappy with Amazon-Whole Foods Deal

Medicinal Marijuana Company Doubles Revenue But Struggles to Break Even
STOCKS

These products from Medical Marijuana are legal in all 50 states

Google and Novartis Back Medicxi's New $300 Million Fund
HEALTH

There's a new biotech fund out there... and it's got $300 million

Exact Sciences in Talks to Buy Genomic Health - Report
HEALTH

Epizyme's eventual rebound may show promise with results from cancer drug.

AstraZeneca's Big Bet on Oncology May Finally Pay Off
HEALTH

AstraZeneca drops partnership with Regulus after ditching drug

Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion
HEALTH

Who is next for TMO's insatiable M&A appetite?

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
HEALTH

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

How Siri, Cortana Technologies Are Making Their Way Into Hospitals
HEALTH

Here's the technology that big banks, doctors, and startups are all using

Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
HEALTH

Amgen Wants to Boost Label on Powerhouse Repatha

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold
HEALTH

Can healthcare giant Integra continue to grow? Signs point to yes.

Shanda Goes Active on Community Health
HEALTH

Community Health to Sell Hospitals in Pennsylvania